Angion Biomedica Corp.
Angion Biomedica Corp. (ANGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANGN · as of Jun 9, 2026
Key Statistics
Explore Angion Biomedica Corp. Data
angn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 25.0%
The ANGN analyst consensus is Hold, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing +50.00% upside from the current price of $1.00.
Competitors & Peers
angn competitorsANGN
ALNA
AMHV
CHRO
CWBR
EMMLFStock Performance
Full HistoryAbout Angion Biomedica Corp.
Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ d…
what is angion biomedica corp. · angn stock overview · angion biomedica corp. company profile · who is angion biomedica corp. ceo · angn NASDAQ · angion biomedica corp. headquarters · angion biomedica corp. business segments
About Stock Overview & Key Data
Angion Biomedica Corp. (ANGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, ANGN stock price is $1.00, with a market capitalization of $30.1M. The stock has returned -10.71% over the past 12 months and +14.69% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Angion Biomedica Corp. stock is Hold, with an average 12-month price target of $1.50. In fiscal year 2025, Angion Biomedica Corp. reported revenue of — and net income of -$39.6M. For detailed data — including Angion Biomedica Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Angion Biomedica Corp. (ANGN) stock price is $1.00. The stock is traded on NASDAQ under the ticker symbol ANGN. The 52-week range is $1.00 – $20.40.